Related Experiment Video
Updated: Mar 15, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to
Olivia A Skrobot1, Johannes Attems2, Margaret Esiri3
1Dementia Research Group, School of Clinical Sciences, Faculty of Health Sciences, University of Bristol, Learning and Research Level 1, Southmead Hospital, Bristol, BS10 5NB, UK.
Insights
New guidelines (VCING) provide a standardized approach for assessing cerebrovascular disease in post-mortem brains, improving the diagnosis of vascular cognitive impairment. These reproducible criteria help neuropathologists predict the likelihood of cognitive impairment contribution from vascular factors.
Area of Science:
- Neuropathology
- Neuroscience
- Vascular Dementia Research
Background:
- Standardized post-mortem assessment protocols for vascular cognitive impairment (VCI) are lacking.
- Cerebrovascular disease is a significant contributor to cognitive decline, necessitating reliable diagnostic methods.
Purpose of the Study:
- To develop and validate a consensus-based neuropathology guideline (VCING) for assessing cerebrovascular disease in relation to VCI.
- To establish reproducible criteria for post-mortem scoring of various pathologies and determine their predictive value for cognitive impairment.
Main Methods:
- A Delphi method survey was used to agree on sampling protocols and scoring criteria among UK neuropathologists.
- Inter-rater reliability was assessed using Gwet's AC2 coefficient.
- The VCING criteria were validated through blinded post-mortem assessment of 113 individuals with prior cognitive evaluations.
Main Results:
- High inter-rater agreement (AC2 > 0.8) was achieved for most assessed pathologies, including cerebral amyloid angiopathy, infarcts, and microhaemorrhages.
- Arteriolosclerosis and microinfarct severity showed moderate agreement (0.45-0.84).
- Seven key pathologies (leptomeningeal cerebral amyloid angiopathy, large/lacunar infarcts, microinfarcts, arteriolosclerosis, perivascular space dilation, myelin loss) significantly predicted cognitive impairment.
Conclusions:
- The developed Vascular Cognitive Impairment Neuropathology Guidelines (VCING) are reproducible and clinically predictive.
- A preferred predictive model incorporating occipital leptomeningeal cerebral amyloid angiopathy, occipital white matter arteriolosclerosis, and large infarcts achieved 77% accuracy.
- VCING criteria will aid neuropathologists in reporting the likelihood of cerebrovascular disease contributing to cognitive impairment.
Abstract:
There are no generally accepted protocols for post-mortem assessment in cases of suspected vascular cognitive impairment. Neuropathologists from seven UK centres have collaborated in the development of a set of vascular cognitive impairment neuropathology guidelines (VCING), representing a validated consensus approach to the post-mortem assessment and scoring of cerebrovascular disease in relation to vascular cognitive impairment. The development had three stages: (i) agreement on a sampling protocol and scoring criteria, through a series of Delphi method surveys; (ii) determination of inter-rater reliability for each type of pathology in each region sampled (Gwet's AC2 coefficient); and (iii) empirical testing and validation of the criteria, by blinded post-mortem assessment of brain tissue from 113 individuals (55 to 100 years) without significant neurodegenerative disease who had had formal cognitive assessments within 12 months of death. Fourteen different vessel and parenchymal pathologies were assessed in 13 brain regions. Almost perfect agreement (AC2 > 0.8) was found when the agreed criteria were used for assessment of leptomeningeal, cortical and capillary cerebral amyloid angiopathy, large infarcts, lacunar infarcts, microhaemorrhage, larger haemorrhage, fibrinoid necrosis, microaneurysms, perivascular space dilation, perivascular haemosiderin leakage, and myelin loss. There was more variability (but still reasonably good agreement) in assessment of the severity of arteriolosclerosis (0.45-0.91) and microinfarcts (0.52-0.84). Regression analyses were undertaken to identify the best predictors of cognitive impairment. Seven pathologies-leptomeningeal cerebral amyloid angiopathy, large infarcts, lacunar infarcts, microinfarcts, arteriolosclerosis, perivascular space dilation and myelin loss-predicted cognitive impairment. Multivariable logistic regression determined the best predictive models of cognitive impairment. The preferred model included moderate/severe occipital leptomeningeal cerebral amyloid angiopathy, moderate/severe arteriolosclerosis in occipital white matter, and at least one large infarct (area under the receiver operating characteristic curve 77%). The presence of 0, 1, 2 or 3 of these features resulted in predicted probabilities of vascular cognitive impairment of 16%, 43%, 73% or 95%, respectively. We have developed VCING criteria that are reproducible and clinically predictive. Assuming our model can be validated in an independent dataset, we believe that this will be helpful for neuropathologists in reporting a low, intermediate or high likelihood that cerebrovascular disease contributed to cognitive impairment.10.1093/brain/aww214_video_abstractaww214_video_abstract.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Dementia
The progression of dementia is generally gradual....
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

